Implanet SA
PAR:ALIMP

Watchlist Manager
Implanet SA Logo
Implanet SA
PAR:ALIMP
Watchlist
Price: 0.243 EUR -2.8%
Market Cap: 34.9m EUR

Gross Margin
Implanet SA

52.1%
Current
57%
Average
47.5%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52.1%
=
Gross Profit
5.8m
/
Revenue
11.1m

Gross Margin Across Competitors

No Stocks Found

Implanet SA
Glance View

Market Cap
34.9m EUR
Industry
Health Care

Implanet SA engages in manufacturing implants designed for orthopedic surgery. The company is headquartered in Martillac, Nouvelle-Aquitaine. The company went IPO on 2013-11-25. The company is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The firm's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors, among others. Its activities, and flagship products, include JAZZ (Spine System) and MADISON (Knee implant). JAZZ implant is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery. MADISON implant is designed for first-line prosthetic knee surgery.

ALIMP Intrinsic Value
0.091 EUR
Overvaluation 63%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52.1%
=
Gross Profit
5.8m
/
Revenue
11.1m
What is the Gross Margin of Implanet SA?

Based on Implanet SA's most recent financial statements, the company has Gross Margin of 52.1%.

Back to Top